{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fntrk-testing-Rr9vC8YL","width":444,"version":"1.0","type":"rich","title":"Rationale for NTRK Testing in Patients With Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/554a3e3a-f14e-46b2-9b5e-b35b09aac32b/ntrk-podcasticon.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/72f8a13f-18cb-48aa-bcbe-8bd5d8de74ea\" height=\"200\" width=\"100%\" title=\"Rationale for NTRK Testing in Patients With Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast episode, join George D. Demetri, MD, and Alexander Drilon, MD, to learn why, when, and how to test for NTRK fusions in patients with diverse solid tumors."}